Safety and Efficacy of Fecal Microbiota Transplantation in Alleviating Symptoms of Parkinson's Disease: A Randomized, Placebo‐Controlled, Double‐Blinded Study
A single FMT does not influence motor symptoms manifestation in patients with PD but could improve non-motor functioning via gut-brain axis. Trial registration information: Clinical Trial ID NCT05204641 was submitted on November 29, 2021. The first patient was enrolled on January 4, 2022. ANN NEUROL 2026.
Authors
- Jarosław Biliński (ORCID: https://orcid.org/0000-0001-8286-4512)
- Julia M. Nowak (ORCID: https://orcid.org/0009-0001-3766-165X)
- Weronika Zając (ORCID: https://orcid.org/0000-0001-7174-8241)
- Aleksandra Antoniak
- Dariusz Koziorowski (ORCID: https://orcid.org/0000-0001-8920-8024)
- Stanisław Szlufik (ORCID: https://orcid.org/0000-0003-4188-5901)
- Łukasz Hołubiuk
- Andrzej Friedman (ORCID: https://orcid.org/0000-0002-4390-2739)
- Łukasz Milanowski
- Karol Sadowski
- Weronika Walęcik‐Kot
- Barbara Kaczmarczyk
- Mateusz Kopczyński
- Monika Figura
Institutions
- Medical University of Warsaw (PL)
- University of Gdańsk (PL)
- Grochowski Hospital (PL)
Publication Details
- Journal
- Annals of Neurology
- Published
- 2026-02-12
- DOI
- https://doi.org/10.1002/ana.78153
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.00